Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Virology|March 9, 2007
Antiviral effects of antisense morpholino oligomers in murine coronavirus infection modelsRenaud Burrer, Benjamin W Neuman, Joey P C Ting, et al.
Advanced Drug Delivery Reviews|November 27, 2007
Cell penetrating peptide conjugates of steric block oligonucleotidesBernard Lebleu, Hong M Moulton, Rachida Abes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouseSue Fletcher, Kaite Honeyman, Abbie M Fall, et al.
Nucleic Acids Research|September 18, 2008
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studiesRachida Abes, Hong M Moulton, Philippe Clair, et al.
International Journal of Molecular Sciences|December 10, 2021
A <i>Dystrophin</i> Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon SkippingYusuke Echigoya, Nhu Trieu, William Duddy, et al.
Journal of Virology|March 30, 2005
Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replicationTia S Deas, Iwona Binduga-Gajewska, Mark Tilgner, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infectionDana L Swenson, Kelly L Warfield, Travis K Warren, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2022
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophyKenji Rowel Q Lim, Stanley Woo, Dyanna Melo, et al.
Pageof 7